Breakthrough Tracker record
A Streptomyces megacluster encodes a naturally coordinated multi-drug antibiotic system
A conserved Streptomyces biosynthetic megacluster was shown to produce four natural-product families plus streptavidin that converge on bacterial biotin metabolism through complementary mechanisms. Stravidin S2 and alpha-Me-KAPA acted synergistically and improved efficacy in a mouse model of multidrug-resistant E. coli infection.
← Back to the filtered Breakthrough Tracker
- Stable ID
science-2026-streptomyces-antibiotic-megacluster- Revision
science-2026-streptomyces-antibiotic-megacluster.v1- Field
- Biology · Microbiology and antibiotic discovery
- Evidence
- Tier 2 · Peer reviewed: Yes
- Record state
- Current · Peer-reviewed preclinical result
- Last checked
AI role
No substantive AI role was reported.
Record details
- Problem or result
- Conventional antibiotic discovery often isolates one molecule at a time and may miss naturally co-evolved combinations that attack a pathway at several points.
- Authors
- R. Gordzevich, M. Xu, W. Wang et al.
- Institutions
- McMaster University Institute of Infectious Disease Research; Biochemistry and Biomedical Sciences; David Braley Centre for Antibiotic Discovery
- Result date
- June 24, 2026
Why it matters
The work reveals naturally encoded combination therapy as an underexplored antibiotic-discovery strategy.
Limits
The efficacy evidence is preclinical; pharmacokinetics, toxicity, dosing, manufacturing and resistance evolution in humans are unknown. These compounds are not an approved treatment.
Sources
- Primary: Nature primary paper
- Primary: Code archive
- Independent: Nature editorial reporting
Correction and revision history
- 2026-06-24 — Mechanistic and mouse-efficacy study published in Nature.
Machine-readable: JSON v1 · CSV v1 · Schema v1
This individual record remains noindex until a story-specific featured image passes Kingy’s rendered-pixel visual review. The source-linked tracker hub remains the public index.